[at Motley Fool] – The patent cliff hits Eli Lilly (LLY) hard in 2014. Here’s how Lilly hopes to survive the sales headwind and compete against AstraZeneca (AZN), Novo Nordisk (NVO) and Sanofi (SNY)
Read more on this.
Eli Lilly & Co. (NYSE:LLY) | Eli Lilly & Co.: Big Pharma Checkup for 2014
January 10, 2014 at 18:30 PM EST
[at Motley Fool] – The patent cliff hits Eli Lilly (LLY) hard in 2014. Here’s how Lilly hopes to survive the sales headwind and compete against AstraZeneca (AZN), Novo Nordisk (NVO) and Sanofi . . . → Read More: Eli Lilly & Co. (NYSE:LLY) | Eli Lilly & Co.: Big Pharma Checkup for 2014
